Paraplegia after intrathecal mitozantrone.
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002493:Central Nervous System Diseases / Q000188:drug therapy; D006801:Humans; D007278:Injections, Spinal / Q000009:adverse effects; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects*; D010264:Paraplegia / Q000139:chemically induced*
D000970:Antineoplastic Agents; D008942:Mitoxantrone